San Francisco, CA, United States of America

Troy Reynolds

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Sierra Oncology, Inc., Glaxosmithkline LLC. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Troy Reynolds. Retrieved from https://idiyas.com/inventor/troy-reynolds-tv11szy3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Troy Reynolds

Introduction

Troy Reynolds, an accomplished inventor based in San Francisco, CA, has made significant strides in the field of pharmaceuticals. With a total of three patents to his name, Reynolds is recognized for his innovative contributions that aim to improve the therapeutic landscape. His work focuses mainly on novel chemical compounds and their applications in medical formulations.

Latest Patents

Reynolds holds notable patents, including one for N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide. This invention pertains to stable novel salt forms of this compound, which are designed to be suitable for the preparation of pharmaceutical formulations and their therapeutic use. The implications of such work are vast, as these formulations have the potential to enhance treatment efficacy for various medical conditions.

Career Highlights

Throughout his career, Troy Reynolds has been associated with prominent companies in the pharmaceutical sector, including Sierra Oncology, Inc. and GlaxoSmithKline LLC. His experience in these organizations has helped him refine his skills and focus his efforts on impactful research and development in drug innovation.

Collaborations

Reynolds has had the opportunity to collaborate with talented professionals in the field, including coworkers Brandon H. Brown and Ernest A. Carra. These collaborations have likely contributed to his successful patent applications and reinforced his position as an influential figure in pharmaceutical innovation.

Conclusion

Troy Reynolds continues to be a pivotal inventor within the pharmaceutical industry. His patents not only emphasize his innovative thinking but also underscore the significance of research in developing therapies that can improve patients' lives. As he advances his work, the potential for future inventions remains promising and inspiring for the field of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…